bg
A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD2.73
  • USD2.99
  • USD2.65
  • USD5.78
  • 1.90%
  • 0M
  • 1.42M
  • 1.85M
  • 569M
  • 2.01
  • -3.90%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.